Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease
Study context
- Population
- Patients aged 35–80 years at elevated risk of Atherosclerotic Cardiovascular Disease (ASCVD) with uncontrolled SBP and LDL-Cestimated enrollment
- Participants
- 2,420 patients
- Planned comparison
- Penn Medicine Healthy Heart vs usual care
- Primary endpoint
- Improvement in SBP and LDL-C
- Follow-up
- 6 months
Methodological detailsdesign and rationale, primary care practices, University of Pennsylvania Health System, Enrolling (1,240 enrolled as of August 15, 2024), Enrollment March 2024-March 2025; 6-month intervention with 12-month follow-up
- Design and rationale
- Primary care practices, University of Pennsylvania Health System
- Enrolling (1,240 enrolled as of August 15, 2024)
- Enrollment March 2024-March 2025; 6-month intervention with 12-month follow-up
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease. Am Heart J. Published 27 September 2024. doi:10.
Summarised from the published abstract; every number is checked against it